You are here

Eli Lilly

Eli Lilly says it's cutting an average of 50% off list prices—and its price hikes don't work

Fierce Pharma

Tue, 03/21/17 - 11:10 am

Novartis star Cosentyx, facing new rivals, may gain edge as a disease-modifying med

Fierce Pharma

Tue, 03/21/17 - 10:00 am

Valeant Pharmaceuticals

Phase 3 win moves Lilly's breast cancer drug closer to market

BioPharma Dive

Mon, 03/20/17 - 11:31 pm

Diabetes meds from AZ, J&J and Lilly sharply cut death rates in real-world analysis

Fierce Pharma

Mon, 03/20/17 - 10:57 am

Boehringer Ingelheim

SGLT2 inhibitor

Lilly's breast cancer drug combination succeeds key study

Yahoo/Reuters

Mon, 03/20/17 - 10:49 am

clinical trials

Merck and Pfizer prep for battle with SGLT2, combo diabetes filings

Fierce Pharma

Mon, 03/13/17 - 10:18 am

SGLT2 inhibitor

Boehringer Ingelheim

The new CEOs in biopharma are joining the big players at the billion-dollar chip table

Endpoints

Fri, 03/10/17 - 09:16 pm

CoLucid Pharmaceuticals

Gilead Sciences

Eli Lilly: Here's One Drug Company Ready to Rally

TheStreet.com

Wed, 03/8/17 - 05:31 pm

Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's

Bloomberg

Thu, 03/2/17 - 10:16 am

Alzheimer's disease

drug development

Eli Lilly Announces Management Changes

TheStreet.com

Thu, 03/2/17 - 09:46 am

Pharma heads write to Congress... and put foot in mouth

Forbes

Sun, 02/26/17 - 12:57 pm

The Demise Of The Erectile Dysfunction TV Ads

Forbes

Fri, 02/24/17 - 11:12 am

erectile dysfunction

Top 10 U.S. patent losses of 2017

Fierce Pharma

Thu, 02/23/17 - 09:29 am

Sandostatin LAR

Bristol-Myers Squibb

Gilead Sciences

Eli Lilly wins label expansion for Trulicity injection with basal insulin

Endpoints

Wed, 02/8/17 - 09:39 pm

After promising Trump new US jobs, Eli Lilly sets out to chop 200 R&D staffers

Endpoints

Sun, 02/5/17 - 12:51 pm

Transcript of Pharma CEOs Meeting With Trump

Investors Hub

Wed, 02/1/17 - 09:45 am

Pharma goes to Washington, Trump talks pricing

BioPharma Dive

Wed, 02/1/17 - 09:41 am

pharma industry

Lilly Misses Analysts’ Estimates as Sales of Older Products Fall

Bloomberg

Tue, 01/31/17 - 10:35 am

Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit

Yahoo/Reuters

Tue, 01/31/17 - 10:09 am

price collusion

Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more

BioPharma Dive

Sat, 01/28/17 - 02:39 pm

Gilead Sciences

Pages